Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Neuronal Signaling >  5-HT Receptor modulators >  Asenapine Maleate

Asenapine Maleate

Basic information Safety Supplier Related

Asenapine Maleate Basic information

Product Name:
Asenapine Maleate
Synonyms:
  • trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole maleate
  • Org 5222
  • Asenapine maleate
  • Einecs 288-064-8
  • Unii-cu9463U2E2
  • 1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, 5-chloro-2,3,3a,12b-tetrahydro-2-methyl-, trans-, (Z)-2-butenedioate (1:1)
  • Org 5222 Maleate
  • Org5222 Maleate
CAS:
85650-56-2
MF:
C21H20ClNO5
MW:
401.84
EINECS:
288-064-8
Product Categories:
  • Inhibitors
  • Saphris
  • API
Mol File:
85650-56-2.mol
More
Less

Asenapine Maleate Chemical Properties

Melting point:
141-145°
Flash point:
9℃
storage temp. 
2-8°C
solubility 
H2O: ≥10mg/mL
pka
pK1 <3, pK2 7.52, pK3 8.51(at 25℃)
form 
powder
color 
white to off-white
Water Solubility 
Water : 6.25 mg/mL (15.55 mM; Need ultrasonic and warming)
InChIKey
GMDCDXMAFMEDAG-CHHFXETESA-N
More
Less

Safety Information

Hazard Codes 
Xn,N,T,F
Risk Statements 
22-36/37/38-50/53-39/23/24/25-23/24/25-11
Safety Statements 
26-60-61-45-36/37-16
RIDADR 
UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany 
3
HS Code 
29339900
More
Less

Asenapine Maleate Usage And Synthesis

Description

Asenapine, a dual antagonist of dopamine D2and serotonin 5-HT2receptors, was launched for the acute treatment of schizophreniaand manic or mixed episodes associated with bipolar I disorder in adults. Asenapine exhibits high affinity for serotonin 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT5, 5-HT6, and 5-HT7 receptors (Ki = 2.5, 4.0, 0.06, 0.16, 0.03, 1.6, 0.25, and 0.13 nM, respectively); dopamine D1, D2, D3, and D4 receptors (Ki = 1.4, 0.42, 1.1, and 1.3 nM, respectively); a1- and a2-adrenergic receptors (Ki = 1.2 and 1.2 nM, respectively); and histamine H1 receptors (Ki = 1.0 nM), and moderate affinity for H2 receptors (Ki = 6.2 nM). In in vitro assays, asenapine acts as an antagonist at these receptors. Asenapine has no appreciable affinity for muscarinic cholinergic receptors (e.g., Ki = 8128 nM for M1). Despite its potent binding affinity for multiple receptors, the efficacy of asenapine in schizophrenia is thought to be primarily mediated through a combination of antagonist activity at D2 and 5-HT2A receptors.

Chemical Properties

White Solid

Originator

Organon (US)

Uses

Antipsychotic;serotonin 5-HT receptors

Uses

Asenapine maleate has been used as a stressor in studying the Fos expression in forebrain structures of rat models.

Uses

Asenapine Maleate is a 5-HT receptor antagonist developed for the treatment of acute schizophrenia and bipolar mania.

Definition

ChEBI: (S,S)-asenapine maleate is a maleate salt obtained by combining equimolar amounts of (S,S)-asenapine and maleic acid. It contains a (S,S)-asenapine(1+). It is an enantiomer of a (R,R)-asenapine maleate.

brand name

Saphris

General Description

Asenapine is a new atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder. The drug is marketed under the trade names Saphris? and Sycrest. This certified solution standard is suitable for LC/MS or GC/MS applications in clinical toxicology, forensic testing, or pharmaceutical research.

Biochem/physiol Actions

Asenapine maleate is a 5-HT receptor antagonist (5-HT1A,1B, 5-HT2A, 2B, 2C, 5-HT5A, 5-HT6 and 5-HT7), a D2 antagonist, and an antipsychotic.

Side effects

The most common adverse effects associated with asenapine treatment include insomnia, somnolence, nausea, anxiety, agitation, headache, vomiting, constipation, and psychosis. In placebo-controlled trials with risperidone, aripiprazole, and olanzapine in elderly subjects with dementia, there was a higher incidence of cerebrovascular adverse reactions (cerebrovascular accidents and transient ischemic attacks) including fatalities compared to placebo-treated subjects. Asenapine is not approved for the treatment of patients with dementia-related psychosis.

Synthesis

The chemical synthesis of asenapine can be achieved by several different methods. A concise synthesis of asenapine begins with the Horner-Emmons condensation of diethyl (5-chloro-2-fluoro)benzyl phosphonate with salicylaldehyde to produce the corresponding stilbene derivative, which undergoes a 1,3-dipolar cycloaddition reaction with trimethylamine-N-oxide in the presence of lithium diisopropylamide to furnish a trans-3,4-diarylpyrrolidine intermediate. Then, a base-catalyzed intramolecular cyclization involving the nucleophilic displacement of the fluoro group by the phenolic hydroxyl group affords asenapine, which is finally treated with maleic acid in ethanol to yield the corresponding maleate salt.

storage

Store at +4°C

Asenapine MaleateSupplier

Anqing Runke Biomedical Technology Co., Ltd. Gold
Tel
0556-5282330 18075373931
Email
sales@growingchem.com
Suzhou Zehou Biotechnology Co. , Ltd. Gold
Tel
0512-68716880 18075373931
Email
sales@growingchem.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chemvon Biotechnology Co., Ltd
Tel
021-50790412
Email
info@chemvon.com